Skip to main content
. Author manuscript; available in PMC: 2024 Jan 17.
Published in final edited form as: Aliment Pharmacol Ther. 2023 Jan 10;57(4):378–386. doi: 10.1111/apt.17384

TABLE 4.

Characteristics of first-degree relatives with definite hepatic steatosis

First-degree relatives with hepatic steatosis (n = 47) First-degree relatives without hepatic steatosis (N = 65) p-value*
Age (years)a 43.5 (13.1) 42.4 (15.3)   0.69

BMI (kg/m2)a 35.2 (6.1) 28.8 (5.2) <0.0001

Female, n (%) 32 (68.1%) 41 (63.1%)   0.58

Medical co-morbidities, n (%)
 Hypertension 19 (40.4%) 16 (24.6%)   0.07
 Hypercholesterolemia 15 (31.9%) 19 (29.2%)   0.76
 Type 2 diabetes 14 (29.8%) 11 (17.2%)   0.042

Alcohol use (drinks/week)
 None 41 (87.2%) 55 (84.6%)   0.84
 1–7 2 (4.3%) 5 (7.7%)
 ≥ 7 4 (8.5%) 5 (7.7%)

Tobacco use, n (%) 8 (17.0%) 8 (12.3%)   0.48

Biochemical dataa
 AST (IU/L) 27.7 (19.9) 22.6 (14.2)   0.06
 ALT (IU/L) 45.5 (30.7) 32.9 (24.9)   0.0007
 Bilirubin (mg/dl) 0.5 (0.2) 0.5 (0.3)   0.96
 Albumin (g/dl) 4.0 (0.3) 4.0 (0.3)   0.25
 Total cholesterol (mg/dl) 186.1 (39.8) 174.4 (36.7)   0.17
 HDL (mg/dl) 45.2 (9.6) 51.8 (11.1)   0.003
 LDL (mg/dl) 105.2 (36.5) 95.3 (31.7)   0.25
 TG (mg/dl) 178.6 (91.2) 125.3 (80.8)   0.0003
Platelet count (109/L) 253.1 (67.0) 269.6 (58.5)   0.094
 HbA1c (%) 6.4 (1.5) 6.1 (1.5)   0.01

FIB-4 indexa 0.8 (0.4) 0.7 (0.4)   0.24

FIB-4 Ȧ 2.67, n (%) 0 1 (1.6%)   1.00

Note: Bold values represent the significance of p-value (p < 0.05).

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HbA1c, glycated haemoglobin; HCC, hepatocellular carcinoma; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.

a

Mean (SD).

*

p-values for biochemical data from Wilcoxon two-sample test, otherwise from the t test, chi-square or Fisher’s as appropriate.